← Back
Data updated: Mar 10, 2026
ROYCE LABS
Cardiovascular
ROYCE LABS is a pharmaceutical company focused on Cardiovascular.
-
Since
2
Drugs
-
Trials
41
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
HALOPERIDOL 2025-12-18
HALOPERIDOL 2025-02-26
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
HALOPERIDOL 2025-01-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 100%
1 drugs
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (1)
Company Info
- First Approval
- -
- Latest
- -
- Applications
- 8